1-6 of 6
Laura Notarfranchi, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Short-Term Risk of Progression of Patients with Asymptomatic Monoclonal Gammopathies to Active Multiple Myeloma: The Critical Impact of the Tumoral Mass

Anna Benedetta Dalla Palma, MD, Laura Notarfranchi, MD, Jessica Crosara, MD, Mario Pedrazzoni, MD, Fabrizio Accardi, MD, Valentina Marchica, MS, Denise Toscani, PhD, Emanuela Vicario, PhD, Paola Storti, PhD, Nicola Giuliani
Journal: Blood
Blood (2019) 134 (Supplement_1): 1795.
https://doi.org/10.1182/blood-2019-128252
Published: 2019
Journal Articles

Effect of Continuous Lenalidomide Treatment on Copy Number Alteration and Cytogenetic Abnormalities in Multiple Myeloma Cells

Paola Storti, PhD, Marina Bolzoni, PhD, Francesca Novara, PhD, Giannalisa Todaro, PhD, Valentina Marchica, Federica Costa, PhD, Tania Maldacena, PhD, Laura Notarfranchi, MD, Fabrizio Accardi, MD, Orsetta Zuffardi, PhD, Franco Aversa, MD, Nicola Giuliani, MD PhD, Gabriella Sammarelli, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3039.
https://doi.org/10.1182/blood.V130.Suppl_1.3039.3039
Published: 2017
Journal Articles

Soluble CX3CL1/Fractalkine Is a New Player in the Pro-Inflammatory Microenvironment of Multiple Myeloma Patients Related to Bone Marrow Plasma Cell Infiltration and Neo-Vascularization

Anna Corcione, Valentina Marchica, Elisa Ferretti, Denise Toscani, PhD, Marina Bolzoni, PhD, Federica Costa, PhD, Cristina Mancini, MD, Eugenia Martella, MD, Fabrizio Accardi, MD, Laura Notarfranchi, MD, Domenico Ribatti, MD, Angelo Vacca, MD PhD, Franco Aversa, MD, Vito Pistoia, MD, Nicola Giuliani, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3044.
https://doi.org/10.1182/blood.V130.Suppl_1.3044.3044
Published: 2017
Journal Articles

Phase II Study of the Combination of Interleukin-2 with Zoledronic Acid As Maintenance Therapy Following Autologous Stem Cell Transplant in Patients with Multiple Myeloma

Gabriele Buda, MD PhD, Rita Fazzi, Giovanni Carulli, MD, Sara Galimberti, MD PhD, Paola Sammuri, Enrico Orciuolo, MD PhD, Iacopo Petrini, Fabrizio Accardi, MD, Laura Notarfranchi, MD, Nicola Giuliani, Mario Petrini
Journal: Blood
Blood (2016) 128 (22): 5697.
https://doi.org/10.1182/blood.V128.22.5697.5697
Published: 2016
Journal Articles

Bone Marrow DKK-1 Levels in Smoldering Multiple Myeloma Patients: A New Independent Risk Factor for Progression

Benedetta Dalla Palma, MD, Valentina Marchica, Fabrizio Accardi, MD, Daniela Guasco, Laura Notarfranchi, MD, Federica Costa, Martina Caviola, Federica De Luca, Luisa Craviotto, MD, Mario Pedrazzoni, MD PhD, Franco Aversa, MD, Nicola Giuliani, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4452.
https://doi.org/10.1182/blood.V128.22.4452.4452
Published: 2016
Journal Articles

Lenalidomide Increases Human Dendritic Cell Maturation in Multiple Myeloma Modulating Both Monocyte Differentiation and Mesenchymal Stromal Cell Inhibitory Properties through Ikaros and Casein Kinase 1 Degradation, Respectively

Federica Costa, Marina Bolzoni, PhD, Rosanna Vescovini, PhD, Valentina Marchica, Fabrizio Accardi, MD, Laura Notarfranchi, MD, Benedetta Dalla Palma, MD, Cristina Manferdini, Gina Lisignoli, Sabrina Manni, PhD, Francesco Piazza, MD, Franco Aversa, MD, Nicola Giuliani, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4464.
https://doi.org/10.1182/blood.V128.22.4464.4464
Published: 2016